Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide STRONG
NCT04589819Phase 4Enrolling by invitation
- Sponsor
- University of South Carolina
- Start
- Dec 2022
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in Tibial Stress Fracture, sponsored by University of South Carolina. Started Dec 2022; status: enrolling by invitation.
02
Drugs
teriparatide
03
Conditions
Tibial Stress Fracture
Beyond the preview
Go deeper on NCT04589819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589819.